evaluate novo nordisk on glp-1 agonists Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Wall Street Underestimates Novo Nordisk's

Clarke et al

Vomiting, diarrhea and constipation occur less frequently but still affect notable numbers of patients

Semaglutide Brand-Name Options: Wegovy (Weight Loss Approval): Approved For: Chronic weight management Dosing: Once-weekly injection, up to 2.4 mg Cost: $1,349/month without insurance Availability: Periodic shortages Ozempic (Diabetes Approval): Approved For: Type 2 diabetes Dosing: Once-weekly injection, up to 2.0 mg Cost: $969/month without insurance Often prescribed off-label for weight loss Compounded Semaglutide: The Most Affordable Option: Cost: $199-$599/month (TrimRx: $199/month) Same active ingredient as Wegovy/Ozempic Available through telehealth platforms Better availability than brand-name options Cost Comparison: Tirzepatide vs Semaglutide: When to Choose Semaglutide Over Tirzepatide: Budget is Primary Concern: Compounded semaglutide at $199/month costs $150/month less than compounded tirzepatide ($349/month)

Resistance training signals the body to hold onto muscle

Accessed 04 Sept 2023

The author declares that there is no conflict of interest